| Drug Name: | Adalimumab (331731-18-1) |
|---|---|
| PubChem ID: | 124081178 |
| SMILES: | CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](COP(=O)(O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)N |
| InchiKey: | ABCAIZUEHBWSOE-PSEVWLGYSA-N |
| Therapeutic Category: | Anti-Inflammatory Agents, Antirheumatic Agents |
| Molecular Weight (dalton) | : | 1001.03 |
| LogP | : | -0.9683 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 13 |
| Hydrogen Bond Donor Count | : | 13 |
| Total Polar Surface Area | : | 408.38 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category